- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
23
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
23 companies
Madrigal Pharmaceuticals
Market Cap: US$12.2b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$529.48
7D
0.4%
1Y
83.1%
Axsome Therapeutics
Market Cap: US$12.6b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$242.60
7D
0.6%
1Y
125.7%
Krystal Biotech
Market Cap: US$11.1b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$374.68
7D
-0.9%
1Y
168.1%
Ionis Pharmaceuticals
Market Cap: US$13.5b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$83.18
7D
3.1%
1Y
99.1%
Royalty Pharma
Market Cap: US$33.3b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$56.92
7D
-0.3%
1Y
59.9%
Alnylam Pharmaceuticals
Market Cap: US$41.8b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$313.04
7D
6.7%
1Y
-3.4%
Insmed
Market Cap: US$24.2b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$111.54
7D
6.5%
1Y
15.0%
BridgeBio Pharma
Market Cap: US$15.1b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$77.75
7D
8.0%
1Y
78.7%
Viatris
Market Cap: US$19.4b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$16.80
7D
3.5%
1Y
82.6%
AbbVie
Market Cap: US$461.3b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$254.76
7D
0.2%
1Y
35.8%
Ascendis Pharma
Market Cap: US$17.0b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$267.92
7D
1.6%
1Y
n/a
Jazz Pharmaceuticals
Market Cap: US$15.3b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$244.17
7D
2.7%
1Y
126.9%
Neurocrine Biosciences
Market Cap: US$17.5b
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
NBIX
US$174.10
7D
2.4%
1Y
36.1%
BeOne Medicines
Market Cap: US$33.1b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$309.46
7D
6.7%
1Y
28.4%
Gilead Sciences
Market Cap: US$163.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$129.61
7D
2.6%
1Y
16.0%
Waters
Market Cap: US$37.2b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$378.89
7D
2.7%
1Y
9.3%
Natera
Market Cap: US$40.0b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$283.80
7D
4.2%
1Y
78.8%
Merck
Market Cap: US$320.0b
Operates as a healthcare company worldwide.
MRK
US$126.78
7D
-2.0%
1Y
56.7%
Bio-Techne
Market Cap: US$11.0b
Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
TECH
US$70.92
7D
0.03%
1Y
37.6%
Elanco Animal Health
Market Cap: US$12.5b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$25.13
7D
1.6%
1Y
73.7%
BioMarin Pharmaceutical
Market Cap: US$11.4b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$58.79
7D
1.9%
1Y
2.4%
ICON
Market Cap: US$13.3b
A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.
ICLR
US$170.94
7D
-1.2%
1Y
15.8%
Charles River Laboratories International
Market Cap: US$11.1b
Charles River Laboratories International, Inc.
CRL
US$231.43
7D
2.6%
1Y
50.4%